tiprankstipranks
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market
Holding TSE:CRDL?
Track your performance easily

Cardiol Therapeutics (CRDL) Financial Statements

152 Followers

Cardiol Therapeutics Financial Overview

Cardiol Therapeutics's market cap is currently ―. The company's EPS TTM is C$-0.531; its P/E ratio is ―; Cardiol Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is C$-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -12.73M$ -6.59M$ -9.18M$ -7.64M$ -5.93M
EBITDA$ -12.53M$ -6.53M$ -9.12M$ -7.57M$ -5.87M
Net Income Common Stockholders$ -12.73M$ -6.59M$ -9.18M$ -7.64M$ -5.93M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.89M$ 24.02M$ 28.57M$ 34.93M$ 40.54M
Total Assets$ 17.52M$ 26.31M$ 31.13M$ 36.70M$ 43.05M
Total Debt$ 165.98K$ 164.27K$ 167.14K$ 174.34K$ 181.21K
Net Debt$ -15.72M$ -23.86M$ -28.41M$ -34.76M$ -40.36M
Total Liabilities$ 7.09M$ 10.95M$ 11.07M$ 8.45M$ 8.18M
Stockholders Equity$ 10.43M$ 15.36M$ 20.06M$ 28.25M$ 34.87M
Cash Flow-
Free Cash Flow$ -7.78M$ -4.78M$ -6.93M$ -6.48M-
Operating Cash Flow$ -7.77M$ -4.78M$ -6.92M$ -6.46M$ -3.41M
Investing Cash Flow$ -7.87K$ -3.80K$ -3.46K$ -10.71K$ -5.58K
Financing Cash Flow$ -4.62K$ 78.08K$ 76.35K$ -13.84K$ -13.84K
Currency in USD

Cardiol Therapeutics Earnings and Revenue History

Cardiol Therapeutics Debt to Assets

Cardiol Therapeutics Cash Flow

Cardiol Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis